Gallbladder Polyps
On this page
Direct answer
Ten millimetres is the line in the sand for gallbladder polyps: at that size, or at 6–9 mm with a risk factor attached, the gallbladder comes out; smaller polyps without risk factors watch on ultrasound at lengthening intervals. The reason the framework exists is that most polyps are cholesterol pseudopolyps — never destined for malignancy — while a small minority are adenomas on the cancer pathway, and size plus shape is the only sorting machine ultrasound provides. In India, where gallstone disease is endemic, polyps are found on every scan list, so the thresholds are ward knowledge, not trivia.
What you must remember
- Pathology spectrum: cholesterol polyps (the majority), inflammatory polyps, adenomyomatosis (focal wall thickening with "comet-tail" artefact), and true neoplastic adenomas — roughly 5%.
- Malignancy risk factors (European guideline list): age above 60, primary sclerosing cholangitis, Asian ethnicity, sessile morphology (no pedicle), and gallbladder wall thickening above 4 mm.
- Resection thresholds: polyp ≥10 mm — cholecystectomy; 6–9 mm with any risk factor — cholecystectomy; polyp in a PSC patient — a very low threshold for surgery.
- Surveillance intervals: 6–9 mm without risk factors — ultrasound at 6 months, 1 year, then annually up to 5 years; polyps under 6 mm without risk factors follow a similar staged schedule, relaxed in the 2022 guideline update.
- Growth rule: interval growth of about 2 mm or more within 2 years upgrades the polyp to resection — documented growth is treated as behaviour, not measurement noise.
- Shape logic: a pedunculated polyp with a visible stalk reassures; a sessile, broad-based lesion without a pedicle is the suspicious morphology.
- Adenomyomatosis is benign: fundal wall thickening with echogenic foci and comet-tail shadowing; it follows, not resects, unless symptomatic or inseparable from malignancy.
- Indian context: the northern "gallstone belt" makes incidental polyps commonplace; the exam expects the size thresholds quoted to the millimetre.
Size, shape and the risk checklist
Run the framework on two patients. The first, a 68-year-old man from Lucknow, has a 7 mm sessile polyp on a routine scan. Two of the five risk factors are present — age over 60 and sessile morphology — and at 6–9 mm with a risk factor, that is a cholecystectomy, justified by the arithmetic of an adenoma-carcinoma pathway in an aged gallbladder. The second, a 34-year-old woman with a 5 mm pedunculated polyp and a clean risk-factor list, watches: ultrasound at 6 months, 1 year, then annually to 5 years, with one instruction that matters more than the schedule — report the growth, not just the size, because a polyp that gained 2 mm since last year has demonstrated behaviour and crosses into surgery. The PSC patient is the third vignette the exam loves: any gallbladder polyp in primary sclerosing cholangitis is treated with a marked bias toward cholecystectomy, because malignancy risk in that biliary tree is already elevated. What the framework quietly teaches is that gallbladder polyp management is an exercise in combining three data points — size, morphology, and host risk — and no single number decides alone.
The pedicle that saves the gallbladder
The examiner's morphology question hides in plain sight: why does sessile shape matter? A polyp with a pedicle is projecting on a stalk — the cholesterol polyp's favourite pose — while a broad-based lesion anchored in the wall resembles the early mass lesions that carcinoma grows as; the absence of a pedicle is therefore an independent risk flag, quoted alongside size. The second trap is the follow-up calendar: candidates memorise "10 mm" and forget that surveillance has both a rhythm (6 months, 1 year, then annual to 5 years) and an expiry — guidelines relaxed the intervals for small stable polyps in their 2022 update precisely because decades of data showed the tiny cholesterol polyp does nothing. Third, know the mimic: adenomyomatosis with its comet-tail artefact is benign hyperplasia, and resecting it "for malignancy" without symptoms or diagnostic doubt is over-treatment — the exam rewards the candidate who can look at the wall thickening and name it.
Frequently asked questions
What size gallbladder polyp mandates cholecystectomy?
A polyp of 10 mm or more; at 6–9 mm, surgery is advised when any risk factor (age over 60, PSC, Asian ethnicity, sessile shape, wall thickening >4 mm) is present.
How are polyps under 6 mm managed?
Surveillance ultrasound at staged intervals — commonly 6 months, 1 year, then annually up to 5 years, with the 2022 European update relaxing intervals for stable small polyps.
What rate of growth triggers surgery?
Documented growth of roughly 2 mm or more within 2 years — interval growth is treated as malignant behaviour.
What is adenomyomatosis?
A benign hyperplastic change with focal wall thickening and echogenic foci producing comet-tail artefact; it is followed, not resected, unless symptomatic or doubtful.
Why do PSC patients with polyps have a low surgical threshold?
Primary sclerosing cholangitis carries elevated biliary tract cancer risk, so any gallbladder polyp is treated with strong bias toward cholecystectomy.